Age |
|
|
Median |
70 years |
Range |
35-82 years |
|
|
n |
% |
|
Gender |
|
|
Female |
8 |
21.0% |
Male |
30 |
79.0% |
Karnofsky performance status |
|
|
40-60% |
12 |
31.6% |
70% |
17 |
44.7% |
80% |
9 |
23.7% |
Histology |
|
|
Urothelial carcinoma |
38 |
100% |
Localization of metastases |
|
|
Thoracic |
18 |
47.4% |
Lumbar |
20 |
52.6% |
Number of metastases |
|
|
Single |
15 |
39.5% |
Multiple |
23 |
60.5% |
Distant extra-osseous metastases |
|
|
Overall |
9 |
23.7% |
Lungs |
6 |
15.8% |
Liver |
5 |
13.2% |
Brain |
2 |
5.3% |
Surgical corset |
|
|
Yes |
6 |
15.8% |
No |
32 |
84.2% |
Treatment indications |
|
|
Instability |
7 |
18.4% |
Neurological symptoms |
1 |
2.6% |
Pain |
30 |
79.0% |
Radiotherapy schedule |
|
|
10 x 3 Gy |
24 |
63.2% |
14 x 2.5 Gy |
3 |
7.9% |
20 x 2 Gy |
11 |
28.9% |
Systemic therapy |
|
|
Chemotherapy |
14 |
36.8% |
Bisphosphonates |
4 |
10.5% |